Inhibition of Ca2+-independent phospholipase A2 affects arachidonate-, not docosahexaenoate-, phospholipid remodeling in U(III) cells.
Birbes
H
H
INSERM U 352, Laboratoire de Biochimie & Pharmacologie, INSA-Lyon, Villeurbanne, France.
Luquain
C
C
Pageaux
J F
JF
Lagarde
M
M
Laugier
C
C
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D002460:Cell Line; D004281:Docosahexaenoic Acids / Q000378:metabolism*; D005260:Female; D009281:Naphthalenes / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D010743:Phospholipids / Q000378:metabolism*; D011753:Pyrones / Q000494:pharmacology*; D051381:Rats; D017154:Stromal Cells / Q000378:metabolism; D014599:Uterus / Q000166:cytology / Q000378:metabolism
D001095:Arachidonic Acids; D009281:Naphthalenes; D010726:Phosphodiesterase Inhibitors; D010743:Phospholipids; D011753:Pyrones; D004281:Docosahexaenoic Acids; C068314:6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one; D010741:Phospholipases A; D054467:Phospholipases A2; D002118:Calcium